Clinical Research
News & Careers
Search the Site
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile


Omeros Corporation 

1420 Fifth Avenue
Suite 2675
Seattle  Washington  98101  U.S.A.
Phone: 206-623-4688 Fax: 206-264-7856



 Company News
Omeros Corporation (OMER) Reports Fourth Quarter And Year-End 2014 Financial Results 3/17/2015 10:03:14 AM
Omeros Corporation (OMER) To Announce Fourth Quarter And Full-Year 2014 Financial Results On March 16, 2015 3/10/2015 9:19:12 AM
Omeros Corporation (OMER)'s Phase 2 OMS721 Trial Resulting in Extended Access for Compassionate Use 2/19/2015 7:41:59 AM
Omeros Corporation (OMER) Closes $84 Million Public Offering of Common Stock And Pre-Funded Warrants 2/4/2015 7:29:46 AM
Omeros Corporation (OMER) Announces Proposed Public Offering Of Common Stock And Pre-Funded Warrants 1/29/2015 7:30:11 AM
Omeros Corporation (OMER) Release: OMS721 Inhibits Thrombus Formation In Sera from aHUS Patients 11/19/2014 12:32:36 PM
Omeros Corporation (OMER) Reports Third Quarter 2014 Financial Results 11/11/2014 7:42:46 AM
Omeros Corporation (OMER) Announces Positive Data for MASP-2 Inhibitor In Experimental Model Of Stroke 11/6/2014 6:20:26 AM
Omeros Corporation (OMER) To Announce Third Quarter 2014 Financial Results On November 10, 2014 11/4/2014 8:49:34 AM
Omeros Corporation (OMER) Release: Omidria™ Granted Pass-Through Reimbursement Status From CMS 10/30/2014 8:14:36 AM